Stelac Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,751
| Closed | -$120K | – | 109 |
|
|
2025
Q1 | $120K | Buy |
3,751
+755
| +25% | +$24.1K | 0.05% | 93 |
|
|
2024
Q4 | $116K | Hold |
2,996
| – | – | 0.05% | 100 |
|
|
2024
Q3 | $135K | Hold |
2,996
| – | – | 0.05% | 93 |
|
|
2024
Q2 | $125K | Hold |
2,996
| – | – | 0.05% | 97 |
|
|
2024
Q1 | $136K | Hold |
2,996
| – | – | 0.06% | 90 |
|
|
2023
Q4 | $139K | Hold |
2,996
| – | – | 0.07% | 77 |
|
|
2023
Q3 | $122K | Hold |
2,996
| – | – | 0.07% | 94 |
|
|
2023
Q2 | $145K | Hold |
2,996
| – | – | 0.06% | 137 |
|
|
2023
Q1 | $148K | Hold |
2,996
| – | – | 0.06% | 137 |
|
|
2022
Q4 | $152K | Sell |
2,996
-190
| -6% | -$9.61K | 0.07% | 133 |
|
|
2022
Q3 | $160K | Hold |
3,186
| – | – | 0.07% | 135 |
|
|
2022
Q2 | $156K | Buy |
3,186
+1,326
| +71% | +$64.9K | 0.06% | 143 |
|
|
2022
Q1 | $112K | Buy |
1,860
+97
| +6% | +$5.84K | 0.04% | 161 |
|
|
2021
Q4 | $140K | Buy |
+1,763
| New | +$140K | 0.04% | 165 |
|